IIFNSARS-CoV-2,

Verónica Durán1,2,3, Eirini Nikolouli4, Shambhabi Chatterjee5,6

  • 1Institute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Helmholtz Centre for Infection Research [HZI], Braunschweig, and the Hannover Medical School [MHH], 30625, Hannover, Germany.

PubMed
概括

I型干扰素减少了人心细胞中的SARS-CoV-2复制,但增强了巨细胞的炎症反应. 这一发现澄清了干扰素免疫在COVID-19严重性中的作用.